Free Trial

BridgeBio Oncology Therapeutics (BBOT) Earnings Date, Estimates & Call Transcripts

BridgeBio Oncology Therapeutics logo
$8.55 0.00 (0.00%)
Closing price 05/22/2026 04:00 PM Eastern
Extended Trading
$8.57 +0.02 (+0.23%)
As of 05/22/2026 04:31 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

BridgeBio Oncology Therapeutics Earnings Summary

BridgeBio Oncology Therapeutics issued Q1 2026 earnings on May 12, 2026, reporting an EPS of -$526.11. With a trailing EPS of -$2.05, BridgeBio Oncology Therapeutics' earnings are expected to decrease next year, from ($2.18) to ($2.21) per share.

Q1 2026 Earnings Resources

Get BridgeBio Oncology Therapeutics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on BridgeBio Oncology Therapeutics and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

BridgeBio Oncology Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q4 20261-$0.55-$0.55-$0.55

BridgeBio Oncology Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
5/12/2026Q1 2026--$526.11--$526.11--

Data powered by Fiscal.ai.

BridgeBio Oncology Therapeutics Earnings - Frequently Asked Questions

BridgeBio Oncology Therapeutics (NASDAQ:BBOT) last announced its quarterly earning data on Tuesday, May 12, 2026. Learn more on BBOT's earnings history.

BridgeBio Oncology Therapeutics (NASDAQ:BBOT) has a recorded net income of -$134.04 million. BBOT has generated -$2.05 earnings per share over the last four quarters.

BridgeBio Oncology Therapeutics' earnings are expected to decrease from ($2.18) per share to ($2.21) per share in the next year.


This page (NASDAQ:BBOT) was last updated on 5/26/2026 by MarketBeat.com Staff.
From Our Partners